Brian Cox

N-type calcium channel blockers in pain and stroke

B. Cox, J. Denyer, Brian Cox, 1998 .

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Paul J. Groot-Kormelink, D. Rowlands, H. Danahay, 2021, Journal of medicinal chemistry.

Therapeutic scope of modulation of non-voltage-gated cation channels.

J. Westwick, M. Gosling, B. Cox, 2005, Drug discovery today.

Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.

S. Burbidge, B. Cox, M. Main, 2000, Molecular pharmacology.

Drug block of the hERG potassium channel: Insight from modeling

M. Sutcliffe, P. Stansfeld, P. Gedeck, 2007, Proteins.

HTS approaches to voltage-gated ion channel drug discovery

Brian Cox, Martyn Banks, Jane C Denyer, 1998 .

Application of high-throughput screening techniques to drug discovery.

B Cox, J C Denyer, A Binnie, 2000 .

TRP channels as drug targets.

J. Westwick, B. Cox, Su Li, 2004, Novartis Foundation symposium.